Also noteworthy is the fact that in patients with primary ALL, the resistance of leukemic cells to cytarabine correlated with the presence of almost all diagnostic genetic anomalies: MLL(11q23.3) (r = 0.32), translocation t(9;22)(q34) (r = 0.09), E2A(19p13.3) (r = 0.54), cMYC(8q24) (r = 0.61), and MYB(6q23.3) (r = 0.50) (Table S6). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.